Matthew R Meyer

Title: Innovations by Matthew R Meyer

Introduction

Matthew R Meyer is an accomplished inventor based in Chesterfield, MO (US). He has made significant contributions to the field of biomolecular measurement, particularly in relation to neurological and neurodegenerative diseases. His work focuses on developing methods that enhance the understanding of biomolecules in biofluids.

Latest Patents

Matthew R Meyer holds a patent for "Methods for measuring concentrations of biomolecules in biofluids." This invention provides innovative methods for measuring the absolute concentration of Tau and other protein, peptide fragments, and proteoforms in cerebrospinal fluid (CSF) and plasma samples collected from subjects. The biomolecules targeted by this patent may be implicated in various neurological and neurodegenerative diseases or disorders. Additionally, the patent includes a method for determining whether a therapeutic agent affects the CSF or plasma concentration of a central nervous system-derived biomolecule. The invention also encompasses kits designed for performing these methods.

Career Highlights

Matthew is associated with C2n Diagnostics LLC, where he applies his expertise in biomolecular research. His work at the company has been pivotal in advancing diagnostic methods that can lead to better understanding and treatment of neurological conditions.

Collaborations

Matthew has collaborated with notable colleagues, including Kristopher Michael Kirmess and Kevin Edward Yarasheski. Their combined efforts contribute to the innovative research and development in the field of biomolecular diagnostics.

Conclusion

Matthew R Meyer is a key figure in the advancement of methods for measuring biomolecules in biofluids, with a focus on neurological health. His contributions through patents and collaborations are vital for the ongoing research in this important area.